Skip to main content

Table 1 Demography of NeurocovBR patients

From: Neurological syndromes associated with COVID-19: a multicenter study in Brazil

 

All patients

Vascular

Encephalopathy

Encephalitis

GBS

Neuropathies

Myelitis

n, (%)

197 (100)

81 (41.1)

68 (34.5)

19 (9.6)

13 (6.6)

12 (6.1)

4 (2.1)

Age, median, (IQR)

57 (43–67)

62 (50–71)

57 (43.5–65)

55 (41.5–60.5)

45 (43–54)

40 (34.25–53)

40 (26–56.25)

Female, n, (%)

109 (55.3)

46 (56.8)

41 (60.3)

8 (42.1)

8 (61.5)

4 (33.3)

2 (50)

Comorbidities, n, (%)

 HBP

84 (42.6)

45 (51.1)

29 (42.6)

5 (26.3)

3 (23.1)

2 (16.7)

0 (0)

 DM

57 (28.9)

28 (31.8)

16 (23.5)

5 (26.3)

2 (15.4)

5 (41.7)

1 (25)

 Obesity

30 (15.2)

14 (15.9)

9 (13.2)

0 (0)

2 (15.4)

5 (41.7)

0 (0)

 Smoker

27 (13.7)

15 (17)

9 (13.2)

1 (5.3)

2 (15.4)

0 (0)

0 (0)

 Autoimmune disease

3 (1.5)

2 (2.3)

1 (5.3)

0 (0)

0 (0)

0 (0)

0 (0)

 No comorbidities

47 (23.9)

18 (20.5)

17 (25)

4 (21.1)

5 (38.5)

1 (8.3)

2 (50)

COVID-19 signs and symptoms, n, (%)

 Fever

135 (68.5)

53 (60.2)

50 (73.5)

13 (68.4)

7 (53.8)

9 (75)

3 (75)

 Cough

126 (64)

55 (62.5)

48 (70.6)

9 (47.4)

5 (38.5)

8 (66.7)

1 (25)

 Sore throat

22 (11.2)

3 (3.4)

15 (22.1)

2 (10.5)

0 (0)

1 (8.3)

1 (25)

 Runny nose

26 (13.2)

2 (2.3)

16 (23.5)

4 (21.1)

3 (23.1)

0 (0)

1 (25)

 Myalgia

47 (23.9)

12 (13.6)

26 (38.2)

4 (21.1)

3 (23.1)

2 (16.7)

0 (0)

 Headache

45 (22.8)

18 (20.5)

20 (29.4)

5 (26.3)

1 (7.7)

1 (8.3)

0 (0)

 Asthenia

53 (26.9)

18 (20.5)

20 (19.4)

5 (26.3)

4 (30.8)

5 (41.7)

1 (25)

 Dyspnea

85 (43.1)

45 (51.1)

32 (47.1)

1 (5.3)

1 (7.7)

6 (50)

0 (0)

 StO2 < 95%

53 (26.9)

33 (37.5)

14 (20.6)

2 (10.5)

1 (7.7)

3 (25)

0 (0)

 Anosmia/hyposmia

32 (16.3)

2 (2.3)

21 (3.8)

6 (31.6)

1 (7.7)

2 (16.7)

0 (0)

 No COVID symptoms

14 (7.1)

7 (8)

1 (1.5)

1 (5.3)

4 (30.8)

0 (0)

1 (25)

COVID-19 severity, n, (%)*

 Asymptomatic

17 (8.6)

11 (13.6)

1 (1.5)

1 (5.3)

4 (30.8)

0 (0)

0 (0)

 Mild

58 (29.4)

15 (18.5)

21 (30.9)

10 (52.6)

6 (46.2)

3 (25)

3 (75)

 Moderate

32 (16.2)

12 (14.8)

14 (20.6)

2 (10.5)

2 (15.4)

1 (8.3)

1 (25)

 Severe

21 (10.7)

9 (11.1)

9 (13.2)

3 (15.8)

0 (0)

0 (0)

0 (0)

 Critical

69 (35)

34 (42)

23 (33.8)

3 (15.8)

1 (7.7)

8 (66.7)

0 (0)

Δt COVID-Neuro, d, median, (IQR)

14 (7–24)

10 (6–14)

18 (12–31)

8 (3–24)

23 (15–24)

24 (16.75–39.5)

18 (11.25–14)

  1. Legends: GBS Guillain-Barré Syndrome, HBP high blood pressure, DM diabetes mellitus. * COVID-19 severity was attributed before the vascular syndrome ictus
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us